U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282639) titled 'App-Based Certified Diabetes Education Therapy (AB-CDE)' on Dec. 05.
Brief Summary: The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to provide personalized recommendations for insulin dosing and carbohydrate intake during exercise or low blood sugar events. We want to find out if DailyDose can help lower blood sugar levels as measured by the hemoglobin A1c (HbA1c) test.
Study Start Date:...